Endothelial ATP-binding cassette G1 in mouse endothelium protects against hemodynamic-induced atherosclerosis

Ross, 1999, Atherosclerosis–an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Glass, 2001, Atherosclerosis. the road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0 Hopkins, 2013, Molecular biology of atherosclerosis, Physiol. Rev., 93, 1317, 10.1152/physrev.00004.2012 Zhou, 2014, Shear stress-initiated signaling and its regulation of endothelial function, Arterioscler. Thromb. Vasc. Biol., 34, 2191, 10.1161/ATVBAHA.114.303422 Chiu, 2011, Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives, Physiol. Rev., 91, 327, 10.1152/physrev.00047.2009 Baldan, 2006, ATP-binding cassette transporter G1 and lipid homeostasis, Curr. Opin. Lipidol., 17, 227, 10.1097/01.mol.0000226113.89812.bb Tall, 2008, HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis, Cell Metab., 7, 365, 10.1016/j.cmet.2008.03.001 Meurs, 2012, The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis, Atherosclerosis, 221, 41, 10.1016/j.atherosclerosis.2011.11.024 Zhu, 2008, Laminar shear stress regulates liver X receptor in vascular endothelial cells, Arterioscler. Thromb. Vasc. Biol., 28, 527, 10.1161/ATVBAHA.107.143487 Liu, 2012, Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice, PLoS One, 7, e39165, 10.1371/journal.pone.0039165 van Hinsbergh, 1990, Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells, Blood, 75, 1991, 10.1182/blood.V75.10.1991.1991 Fu, 2011, A novel mechanism of gamma/delta T-lymphocyte and endothelial activation by shear stress: the role of ecto-ATP synthase beta chain, Circ. Res., 108, 410, 10.1161/CIRCRESAHA.110.230151 Matyash, 2008, Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics, J. Lipid Res., 49, 1137, 10.1194/jlr.D700041-JLR200 Xiao, 2013, Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility, Circulation, 128, 632, 10.1161/CIRCULATIONAHA.113.002714 Fu, 2010, Cholesterol increases adhesion of monocytes to endothelium by moving adhesion molecules out of caveolae, Biochim. Biophys. Acta, 1801, 702, 10.1016/j.bbalip.2010.04.001 Madge, 2001, TNF signaling in vascular endothelial cells, Exp. Mol. Pathol., 70, 317, 10.1006/exmp.2001.2368 Li, 2014, Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis, PLoS One, 9, e87552, 10.1371/journal.pone.0087552 Lu, 2014, Inflammasome and atherogenesis, Curr. Pharm. Des., 20, 108, 10.2174/13816128113199990586 Westerterp, 2014, ATP-binding cassette transporters, atherosclerosis, and inflammation, Circ. Res., 114, 157, 10.1161/CIRCRESAHA.114.300738 Kappus, 2014, Activation of liver X receptor decreases atherosclerosis in Ldlr(-)/(-) mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells, Arterioscler. Thromb. Vasc. Biol., 34, 279, 10.1161/ATVBAHA.113.302781 Tall, 2012, Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis, Arterioscler. Thromb. Vasc. Biol., 32, 2547, 10.1161/ATVBAHA.112.300134 Whetzel, 2010, ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions, Arterioscler. Thromb. Vasc. Biol., 30, 809, 10.1161/ATVBAHA.109.199166 Munch, 2012, Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits, Heart Int., 7, e12, 10.4081/hi.2012.e12 Westerterp, 2010, Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency–brief report, Arterioscler. Thromb. Vasc. Biol., 30, 2103, 10.1161/ATVBAHA.110.212985 Wen, 2012, A role for the NLRP3 inflammasome in metabolic diseases–did Warburg miss inflammation?, Nat. Immunol., 13, 352, 10.1038/ni.2228 Duewell, 2010, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals, Nature, 464, 1357, 10.1038/nature08938 Levin, 2005, Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists, Arterioscler. Thromb. Vasc. Biol., 25, 135, 10.1161/01.ATV.0000150044.84012.68